SD

Shikha Dhawan

SHARE INDIA, Partasia Biopharm, Central Tuberculosis Division, Ministry of Health and Family Welfare, Government of India

ORCID iD 0000-0001-5777-7097

Employment

  • SHARE INDIA Director Programs
    2020 - Present
  • SHARE INDIA Associate Director, http://www.sharefoundations.org/our_team.html
    2017 - 2020
  • Partasia Biopharm Executive Director, http://partasiabiopharm.co.in/about-us/team/dr-shikha-dhawan/
    2016 - Present
  • Central Tuberculosis Division, Ministry of Health and Family Welfare, Government of India Microbiologist, Monitoring and Evaluation National Consultant
    2012 - 2016
  • International Centre For Genetic Engineering and Biotechnology New Delhi Manager-Malaria Vaccines
    2008 - 2012
  • International Centre For Genetic Engineering and Biotechnology New Delhi Research Scientist
    2004 - 2008

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (7)

  • Shikha Dhawan et al (2014) Enhancing TB case detection: Experience in offering upfront Xpert MTB/RIF testing to pediatric presumptive TB and DR TB cases for early rapid diagnosis of drug sensitive and drug resistant TB. PLoS One; 9(8):e105346
    +Save
  • Shikha Dhawan et al (2015) Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175 (2015). PLoS One;10(4):e0117820
    +Save
  • Shikha Dhawan et al (2021) TB and COVID-19 in migrants- Why we need to focus on both conditions (2021). The International Journal of Tuberculosis and Lung Disease;25(5):333-335
    +Save
  • • National Guidelines for HIV-1 Viral Load Testing Laboratories (2018), National AIDS Control Program, Ministry of Health and Family Welfare, Government of India • Operational Guidelines for HIV-1 Viral Load Testing (2018), National AIDS Control Program,…
    +Save
  • • Oral on miRNAs as molecular tools for pulmonary tuberculosis diagnosis and assessment of treatment response. World Lung Conference (WLC), Netherlands 2018 • Poster on Experience with Ethics Committee to seek approval for recruiting people with TB and b…
    +Save
  • • Poster: Diagnosis of Drug Resistant Tuberculosis by Xpert MTB/Rif (CBNAAT) in Extrapulmonary Samples: A Retrospective Analysis from Central India, WLC, Cape Town, 2015 • Poster: GeneXpert MTB/Rif (CBNAAT): Initial analysis of Errors, Indeterminates and…
    +Save
  • • Shikha Dhawan et al (2014) Enhancing TB case detection: Experience in offering upfront Xpert MTB/RIF testing to pediatric presumptive TB and DR TB cases for early rapid diagnosis of drug sensitive and drug resistant TB. PLoS One. 2014 Aug 20;9(8):e1053…
    +Save